Erik Jan Dubbink

Erik Jan Dubbink is a Researcher in the Department of Pathology at Erasmus MC, part of Erasmus University Rotterdam. His work focuses on molecular oncology, genomic profiling, and targeted therapies, with a particular emphasis on circulating tumor DNA analysis and therapeutic resistance mechanisms. He collaborates internationally on studies involving solid tumors, rare genetic syndromes (e.g., Birt-Hogg-Dubé), and neuro-oncological conditions like astrocytoma and oligodendroglioma.

His research integrates clinical diagnostics with translational oncology, aiming to improve patient outcomes through precision medicine approaches. Key areas include developing novel genomic assays, analyzing molecular tumor boards' impact, and understanding metastatic disease progression. Collaborations span academic institutions across Europe, reflecting his interdisciplinary approach to cancer research.

Dr. Dubbink has contributed to over 130 peer-reviewed publications, with recent work published in high-impact journals like Nature Reviews Clinical Oncology and Clinical Cancer Research. His studies often emphasize translational applications, bridging basic research with clinical practice.